Player Undergoes Medical After Liverpool Agree £48m+ Deal To Sign Midfield Star

By on August 28, 2017

Managers are now pressing ahead with their plans for the final days of the summer transfer window so we’ll bring you all the latest news and gossip from around the globe. Today, Liverpool agree a deal to sign Naby Keita next summer….

Naby Keita has undergone a medical after Liverpool agreed a club record deal to sign the midfielder from RB Leipzip but the player won’t arrive until next summer, according to the Liverpool Echo.

Jurgen Klopp has been chasing Keita all summer after identifying him as one of his prime targets but Liverpool found it difficult to agree a fee with a stubborn Leipzig side.

The German outfit refused to sell the midfielder this summer and rejected a number of offers from Liverpool last month despite the player making it clear he wanted to leave.

It looked like the Merseysiders would have to battle-it-out with a host of top European clubs for Keita’s signature when his £48m release clause becomes active next summer.

However, the Liverpool Echo claim the club have moved to agree a deal that will see them pay a premium on top of the £48m clause to secure the 22-year-old’s signature on July 1st 2018.

The newspaper says Keita has undergone his medical in Wilmslow this afternoon ahead of what will be a club record move to Anfield as it eclipses the £36.9m Liverpool paid for Mohamed Salah.

This is an excellent piece of business for the Reds as although they will have to wait a year before Keita links-up with the club, they have still secured one of the best all-round midfielders in Europe.

The Guinea international has been exceptional for Leipzig since joining from Red Bull Salzburg two years ago and helped the club finish second in the Bundesliga last season.

READ MORE –> Liverpool transfer news

His all-action style of play will suit Klopp’s system perfectly and I think he’s going to be a huge success here in the Premier League when he eventually joins Liverpool next summer.

Best of the web

Leave a Reply

Your email address will not be published. Required fields are marked *